The Expression and/or Role of Glycoconjugates in Physiological and Pathological Conditions

A special issue of Biology (ISSN 2079-7737).

Deadline for manuscript submissions: 30 April 2025 | Viewed by 619

Special Issue Editors


E-Mail Website
Guest Editor
Laboratório de Biologia Celular de Glicoconjugados, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
Interests: glycobiology; glycoconjugates; glycosyltransferases; glycoproteins
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Laboratório de Biologia Celular de Glicoconjugados, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
Interests: glycolipids; physiological conditions; pathological conditions

E-Mail Website
Guest Editor
Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
Interests: glycobiology of fungi
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-360, Brazil
Interests: glycoimmunology of infectious diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Glycobiology is a developing field of studying both the structure and functions of glycoconjugates (glycoproteins and glycolipids). Over the past fifteen to twenty years, outstanding studies have demonstrated that glycomolecules are capable of governing numerous biological events. Examples include the following: immune responses, protein–protein and /or protein–carbohydrate interactions, cell signaling pathways, cancer development and progression and host–pathogen interactions, among others. Thanks to technological advances, the study of glycan structures, which is a hallmark of all living cells, is becoming a cutting-edge discipline in basic and clinical research, and has contributed to the discovery of new biomarkers and therapeutic targets for different diseases. In this Research Topic, we invite researchers to contribute papers that address the impact of glycobiology on modern medicine, and how this emerging area of knowledge has contributed to generating new information in both physiological and pathological conditions.

Dr. Leonardo Freire-de-Lima
Dr. Leonardo Marques Da Fonseca
Dr. Célio Geraldo Freire-de-Lima
Dr. Alexandre Morrot
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • glycobiology
  • glycoproteins
  • glycolipids
  • glycosyltransferases
  • glycoconjugates

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: O-glycosylated fibronectin expression in infectious disease: the first description in lesions of patients with cutaneous leishmaniasis
Authors: /
Affiliation: ./
Abstract: Although still neglected in several areas of the biomedical field, especially in parasitology, over the last ten to fifteen years, many outstanding articles have shown that the host’s extracellular matrix (ECM) components play indispensable roles in many biological events. It has been proved by many research groups that the intimate relationship between immune cells, ECM glycoproteins and microbial pathogens is one the factors directing the outcome of infection diseases. Among the different ECM components, the glycoprotein fibronectin (FN) stands out. Since the 90's, it has been demonstrated that FN expression influences the interaction of Leishmania sp, the etiologic agent of leishmaniasis, with the host cell. However, the glycophenotype of the glycoprotein, as well as its impact on the course of infection, are still unknown. Here, we demonstrate for the first time the expression of an O-glycosylated isoform of FN, called oncofetal FN (onf-FN) in lesions of patients with cutaneous leishmaniasis. In addition, we demonstrated that human macrophages present in the inflammatory microenvironment of cutaneous lesions are potential producers of this unusual glycoprotein. Since this oncofetal isoform of FN is structurally different from the plasma one, and able to impact numerous biological events, such as cell migration, modulation of the epithelial-mesenchymal phenotype and production of metalloproteinases, its functions in the course of infection by parasitic protozoa need to be better understood. Taken together, our findings are unprecedented, and report for the first time the expression of O-glycosylated onf-FN in a case of infectious disease.

Back to TopTop